5-19.1-2. Definitions.

(a) “Biological product” means a “biological product” as defined in the “Public Health

Service Act,” 42 U.S.C. § 262.

(b) “Board” means the Rhode Island board of pharmacy.

(c) “Change of ownership” means:

(1) In the case of a pharmacy, manufacturer, or wholesaler that is a partnership, any change

that results in a new partner acquiring a controlling interest in the partnership;

(2) In the case of a pharmacy, manufacturer, or wholesaler that is a sole proprietorship, the

transfer of the title and property to another person;

(3) In the case of a pharmacy, manufacturer, or wholesaler that is a corporation:

(ii) A merger of the corporation into another corporation; or

(iii) The consolidation of two (2) or more corporations resulting in the creation of a new

corporation; or

(iv) In the case of a pharmacy, manufacturer, or wholesaler that is a business corporation,

any transfer of corporate stock that results in a new person acquiring a controlling interest in the

corporation; or

(v) In the case of a pharmacy, manufacturer, or wholesaler that is a non-business

corporation, any change in membership that results in a new person acquiring a controlling vote in

the corporation.

(d) “Compounding” means the act of combining two (2) or more ingredients as a result of

a practitioner’s prescription or medication order occurring in the course of professional practice

based upon the individual needs of a patient and a relationship between the practitioner, patient,

and pharmacist. Compounding does not mean the routine preparation, mixing, or assembling of

drug products that are essentially copies of a commercially available product. Compounding shall

only occur in the pharmacy where the drug or device is dispensed to the patient or caregiver and

includes the preparation of drugs or devices in anticipation of prescription orders based upon

routine, regularly observed prescribing patterns.

(e) “Controlled substance” means a drug or substance, or an immediate precursor of such

drug or substance, so designated under, or pursuant to, the provisions of chapter 28 of title 21.

(f) “Deliver” or “delivery” means the actual, constructive, or attempted transfer from one

person to another of a drug or device, whether or not there is an agency relationship.

(g) “Device” means instruments, apparatus, and contrivances, including their components,

parts, and accessories, intended:

(1) For use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans

or other animals; or

(2) To affect the structure or any function of the body of humans or other animals.

(h) “Director” means the director of the Rhode Island state department of health.

(i) “Dispense” means the interpretation of a prescription or order for a drug, biological

product, or device and, pursuant to that prescription or order, the proper selection, measuring,

compounding, labeling, or packaging necessary to prepare that prescription or order for delivery or

administration.

(j) “Distribute” means the delivery of a drug or device other than by administering or

dispensing.

(k) “Drug” means:

(1) Articles recognized in the official United States Pharmacopoeia or the Official

Homeopathic Pharmacopoeia of the U.S.;

(2) Substances intended for use in the diagnosis, cure, mitigation, treatment, or prevention

of disease in humans or other animals;

(3) Substances (other than food) intended to affect the structure, or any function, of the

body of humans or other animals; or

(4) Substances intended for use as a component of any substances specified in subsection

(k)(1), (k)(2), or (k)(3), but not including devices or their component parts or accessories.

(l) “Equivalent and interchangeable” means a drug, excluding a biological product, having

the same generic name, dosage form, and labeled potency, meeting standards of the United States

Pharmacopoeia or National Formulary, or their successors, if applicable, and not found in violation

of the requirements of the United States Food and Drug Administration, or its successor agency, or

the Rhode Island department of health.

(m) “Interchangeable biological product” means a biological product that the United States

Food and Drug Administration has:

(1) Licensed and determined meets the standards for interchangeability pursuant to 42

U.S.C. § 262(k)(4) or lists of licensed, biological products with reference product exclusivity and

biosimilarity or interchangeability evaluations; or

(2) Determined is therapeutically equivalent as set forth in the latest edition of, or

supplement to, the United States Food and Drug Administration’s Approved Drug Products with

Therapeutic Equivalence Evaluations.

(n) “Intern” means:

(1) A graduate of an American Council on Pharmaceutical Education (ACPE)-accredited

program of pharmacy;

(2) A student who is enrolled in at least the first year of a professional ACPE-accredited

program of pharmacy; or

(3) A graduate of a foreign college of pharmacy who has obtained full certification from

the FPGEC (Foreign Pharmacy Graduate Equivalency Commission) administered by the National

Association of Boards of Pharmacy.

(o) “Legend drugs” means any drugs that are required by any applicable federal or state

law or regulation to be dispensed on prescription only or are restricted to use by practitioners only.

(p) “Limited-function test” means those tests listed in the federal register under the Clinical

Laboratory Improvement Amendments of 1988 (CLIA) as waived tests. For the purposes of this

chapter, limited-function test shall include only the following: blood glucose, hemoglobin A1c,

cholesterol tests, and/or other tests that are classified as waived under CLIA and are approved by

the United States Food and Drug Administration for sale to the public without a prescription in the

form of an over-the-counter test kit.

(q) “Manufacture” means the production, preparation, propagation, compounding, or

processing of a drug or other substance or device or the packaging or repackaging.

(r) “Non-legend” or “nonprescription drugs” means any drugs that may be lawfully sold

without a prescription.

(s) “Person” means an individual, corporation, government, subdivision, or agency,

business trust, estate, trust, partnership, or association, or any other legal entity.

(t) “Pharmaceutical care” is the provision of drugs and other pharmaceutical services

intended to achieve outcomes related to cure or prevention of a disease, elimination or reduction of

a patient’s symptoms, or arresting or slowing of a disease process. “Pharmaceutical care” includes

the judgment of a pharmacist in dispensing an equivalent and interchangeable drug or device in

response to a prescription after appropriate communication with the prescriber and the patient.

(u) “Pharmacist in charge” means a pharmacist licensed in this state as designated by the

owner as the person responsible for the operation of a pharmacy in conformance with all laws and

regulations pertinent to the practice of pharmacy and who is personally in full and actual charge of

such pharmacy and personnel.

(v) “Pharmacy” means that portion or part of a premise where prescriptions are

compounded and dispensed, including that portion utilized for the storage of prescription or legend

drugs.

(w) “Pharmacy technician” means an individual who meets minimum qualifications

established by the board, that are less than those established by this chapter as necessary for

licensing as a pharmacist, and who works under the direction and supervision of a licensed

pharmacist.

(x) “Practice of pharmacy” means the interpretation, evaluation, and implementation of

medical orders; the dispensing of prescription drug orders; participation in drug and device

selection; the compounding of prescription drugs; drug regimen reviews and drug or drug-related

research; the administration of adult immunizations and, medications approved by the department

of health in consultation with the board of pharmacy for administration by a pharmacist except as

provided by § 5-25-7, pursuant to a valid prescription or physician-approved protocol and in

accordance with regulations, to include training requirements as promulgated by the department of

health; the administration of all forms of influenza immunizations to individuals between the ages

of nine (9) years and eighteen (18) years, inclusive, pursuant to a valid prescription or prescriber-

approved protocol, in accordance with the provisions of § 5-19.1-31 and in accordance with

regulations, to include necessary training requirements specific to the administration of influenza

immunizations to individuals between the ages of nine (9) years and eighteen (18) years, inclusive,

as promulgated by the department of health; provision of patient counseling and the provision of

those acts or services necessary to provide pharmaceutical care; the responsibility for the

supervision for compounding and labeling of drugs and devices (except labeling by a manufacturer,

repackager, or distributor of nonprescription drugs and commercially packaged legend drugs and

devices), proper and safe storage of drugs and devices, and maintenance of proper records for them;

and the performance of clinical laboratory tests , provided such testing is limited to limited-function

tests as defined herein ; and engage in the independent prescribing of drugs, drug categories or

devices in accordance with the provision of § 5-19.1-36.1 . Nothing in this definition shall be

construed to limit or otherwise affect the scope of practice of any other profession.

(y) “Practitioner” means a physician, dentist, veterinarian, nurse, or other person duly

authorized by law in the state in which they practice to prescribe drugs.

(z) “Preceptor” means a pharmacist registered to engage in the practice of pharmacy in this

state who has the responsibility for training interns.

(aa) “Prescription” means an order for drugs or devices issued by the practitioner duly

authorized by law in the state in which he or she practices to prescribe drugs or devices in the course

of his or her professional practice for a legitimate medical purpose.

(bb) “Wholesaler” means a person who buys drugs or devices for resale and distribution to

corporations, individuals, or entities other than consumers.

SECTION 2. Chapter 5-19.1 of the General Laws entitled "Pharmacies" is hereby amended

by adding thereto the following section: